News Headline Summary

Wedbush maintains Sarepta Therapeutics (SRPT) with a outperform and lowers the price target from USD 70.00 to USD 60.00

Reaction details:

- Co. shares are unmoved by this latest broker move; trades USD 24.28 last (-1.7%).

Print 18:07, 17 Jan 2013 - US Equities - Source: RANsquawk